Implanted auriculotemporal nerve stimulator for the treatment of refractory chronic migraine

Headache

Volumn 50, Issue 6, 2010, Pages 1064-1069

  Simopoulos, Thomas ^a   Bajwa, Zahid ^a   Lantz, George ^a   Lee, Steve ^a   Burstein, Rami ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Calcitonin gene related protein; CGRP; Headache; Nociceptor; Pain; Trigeminal

Indexed keywords

ALMOTRIPTAN; AMITRIPTYLINE; ATENOLOL; BUTALBITAL PLUS CAFFEINE PLUS PARACETAMOL; CALCITONIN GENE RELATED PEPTIDE; COCODAMOL; DOXEPIN; ELETRIPTAN; FROVATRIPTAN; GABAPENTIN; METAXALONE; OXYCODONE; TOPIRAMATE; TRAMADOL; VALPROIC ACID; VERAPAMIL;

ADULT; ARTICLE; AURICULOTEMPORAL NERVE STIMULATION; CASE REPORT; DISABILITY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; NERVE STIMULATION; NEUROIMAGING; NEUROMODULATION; NOCICEPTIVE RECEPTOR; OUTCOME ASSESSMENT; PERIPHERAL NERVE; PHONOPHOBIA; PRIORITY JOURNAL; PULSE GENERATOR; RATING SCALE; TRANSFORMED MIGRAINE; TREATMENT OUTCOME; TRIGEMINUS NEURALGIA; ELECTRODE IMPLANT; ELECTROSTIMULATION THERAPY; MANDIBULAR NERVE; MIDDLE AGED; MIGRAINE DISORDERS; PAIN MEASUREMENT; PAIN, INTRACTABLE; PROCEDURES;

ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; FEMALE; HUMANS; MANDIBULAR NERVE; MIDDLE AGED; MIGRAINE DISORDERS; PAIN MEASUREMENT; PAIN, INTRACTABLE; TREATMENT OUTCOME;

EID: 77953200682     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2010.01694.x     Document Type: Article

References (25)

1. Schner AJ, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache. 1998 38 : 497 506.
2. Solomon S, Grosberg BM. Retinal migraine. Headache. 2003 43 : 510.
3. Spierings ELH, Schroevers M, Honkoop PC, Sorbi M. Development of chronic daily headache: A clinical study. Headache. 1998 38 : 529 533. (Pubitemid 28429341)
4. Silberstein S, Lipton R. Chronic daily headache including transformed migraine, chronic tension type headache, and medication overuse. In : Silbertein S, Lipton R, Dalessio D, eds. Wolff's Headache and Other Head Pain, 7th edn.
5. Dodick DW, Aurora SK, Turkel CC, et al. Botulinum neurotoxin type a for treatment of chronic migraine: Double-blind, randomized, placebo controlled PREEMPT trials. 14th International Headache Congress: Abstract LBOR 01. September 12, 2009.
6. Silberstein S, Lipton R, Dodick DW, et al. Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial. Headache. 2007 47 : 170 180.
7. Spierings ELH. Chronic daily headache. In : Warfield CA, Bajwa ZH, eds. Principles and Practice of Pain Medicine, 2nd edn.
8. Silberstein S, Silberstein J. Chronic daily headache: Long term prognosis following patient treatment with repetitive DHE. Headache. 1992 32 : 439 445.
9. Saper JR, Hammel RL, Lake AE, et al. Long-term scheduled opioid treatment for refractory headache: Second interim outcome report. Headache. 1998 38 : 401.
10. Jakubowski M, Goor-Aryeh I, Collins B, et al. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors. Headache. 2005 45 : 850 861.
11. Weiner R, Reed K. Peripheral neurostimulatin for control of intractable occipital neuralgia. Neuromodulation. 1999 2 : 217 221.
12. Jasper J, Hayek S. Implanted occipital nerve stimulators. Pain Physician. 2008 11 : 187 200.
13. Trentman TL, Zimmerman RS, Seth N, Hentz JG, Dodick DW. Stimulation ranges, usage ranges and paresthesia mapping during occipital nerve stimulation. Neuromodulation. 2008 11 : 56 61.
14. Goadsby PJ, Lipton RB, Ferrari MK. Migraine - current understanding and treatment. N Engl J Med. 2002 346 : 257 270.
15. Popeney CA, Alo KM. Peripheral neurostimulation for the treatment of chronic diabling transformed migraine. Headache. 2003 43 : 369 375.
16. Oh MY, Ortega J, Bellote JB, Whitling DM, Alo K. Peripheral nerve stimulation for the treatment of occipital neuralgia and transformed migraine using C1-2-3 subcutaneous paddle style elecrode: A technical report. Neuromodulation. 2004 7 : 103 112.
17. Matharu M, Bartsch T, Ward N, et al. Central neuromodulation in chronic migraine patients with suboccipital stimulators: A PET study. Brain. 2004 127 : 220 230.
18. Kosaras B, Jakubowski M, Kainz V, Burstein R. Sensory innervation of the calvarial bones of the mouse. J Comp Neurol. 2009 515 : 331 348.
19. Hammer M, Doleys DM. Perineuronal stimulation in the treatment of occipital neuralgia: A case study. Neuromodulation. 2001 4 : 47 51.
20. Kouroukli I, Neofytos D, Panaretou V, et al. Peripheral subcutaneous stimulation for the treatment of intractable postherpetic neuralgia: Two case reports and literature review. Pain Pract. 2009 9 : 225 229.
21. Rauchwerger JJ, Giordano J, Rozen D, et al. On the therapeutic viability of peripheral nerve stimulation for ilioinguinal neuralgia: Putative mechanisms and possible utility. Pain Pract. 2008 8 : 138 143.
22. Chung JM, Lee KH, Hoi Y, et al. Factors influencing peripheral stimulation produced inhibition of primate spinothalamic tract cells. Pain. 1984 19 : 277 293.
23. Garrison DW, Foreman RD. Effects of transcutaneous electrical nerve stimulation (TENS) on spontaneous and noxiously evoked dorsal horn cell activity in cats with transected spinal cords. Neurosci Lett. 1996 216 : 125 128.
24. Beckmann YY, Secil Y, Kendir AI, Basoglu M. Chronic migraine: A prospective descriptive clinical study in a headache center population. Pain Pract. 2009 9 : 380 384.
25. Jakubowski M, McAllister PJ, Bajwa ZH, Ward TN, Smith P, Burstein R. Exploding vs. imploding headache in migraine prophylaxis with botulinum toxin-A. Pain. 2006 125 : 286 295.